Affordable in home care | starts at $28 per hr

Lung disease: COPD among white and black women

1 / 17

Change in death rate among white women in the USA:

44% History of Asthma ; 38% smokers

10M white women with COPD, 1.4M Black women, 1M Hispanic women

1991-1995: Heart disease death rate: Asian, white, black and Hispanic women (shown in the pictures above)

Dr Axe wrote:

 

Dr. Jonathan V. Wright from the Tahoma Medical Clinic wrote about COPD in the August 2002 “Nutrition and Healing”  COPD Natural Treatments Jonathan V Wright Aug 2002.  The mainstay of his treatment for COPD is nebulized glutathione, a natural treatment which restores glutathione levels to the lung tissue.

Altered Glutathione Levels is Primary Abnormality in COPD

“Alterations in alveolar and lung GSH (glutathione) metabolism are widely recognized as a central feature of many inflammatory lung diseases including chronic obstructive pulmonary disease (COPD).”  (14)

Inhaled Glutathione: Inhaled Glutathione may be taken in a nebulizer.  Originally, the glutathione is made up by a compounding phamacy and shipped to the user.  “Inhaled glutathione requires a prescription and is available from compounding pharmacies such as McGuff Compounding Pharmacy and Wellness Pharmacy. The usual starting dose is 300 mg of glutathione (200 mg/cc, draw 1.5 cc and place in nebulizer) twice a day.  ” (7)  Quote from Julian Whitaker’s newsletter (7).

Glutathione capsules: A more practical method has been devised by Dr Bishop, using capsules.  (Glutathione  capsules from Thera Naturals ) .  Dr. Sircus wrote an article on  Glutathione & Bicarbonate Nebulization using the Glutathione capsules.

Clark T. Bishop, M.D. devised this protocol: Protocol for Augmentation of GSH Levels in Cystic Fibrosis Patients, and Related Information.  Here is a clinical study on the use of Glutathione: by Dr Alfredo Visca, and Clark Bishop, et al. Improvement in clinical markers in CF patients using a reduced glutathione Clark Bishop 2008  Journal of Cystic Fibrosis 7.5 (2008): 433-436.  (8-12)

SSKI to Liquify Secretions: 004001 SSKI (Potassium Iodide Oral Solution, USP), 1gm per mL, 240mL Dropper Bottle McGuffMedical.comThe second treatment is SSKI to liquify secretions and allow clearance of mucous,  SSKI stands for super saturated potassium iodine, an old remedy which works quite well.  Although SSKI has been available at the corner drug store for over 80 years, and is generally considered safe, iodine can suppress thyroid function with an increase in the TSH lab value on thyroid testing.  This elevation of TSH is usually temporary and returns to normal after discontinuing the SSKI. (6)    There is much misinformation or disinformation about the safety of SSKI (see this news report).  The elevation of TSH from SSKI is not life  threatening and is of little or no clinical consequence.  As with most other medical treatments, it is best to work with a knowledgeable doctor who can monitor thyroid function while under treatment.   Left image bottle of SSKI courtesy of McGuff medical Supply.

Resveratrol:  An extract from grapes, Resveratrol, is useful in COPD. see: Antioxidant and anti-inflammatory effects of resveratrol in airway disease. by Wood .   “We conclude that resveratrol has potential as a therapeutic agent in respiratory disease”.  Buy Resveratrol.

Dr Wright’s List of recommended treatments for COPD

Serrapeptidase: mucolytic enzyme shown to be useful in COPD.  see:

Effect of the proteolytic enzyme Serrapeptase in patients with chronic airway disease. by Nakamura S Department of Respiratory Medicine, Tokyo. Respirology. 2003 Sep;8(3):316-20.

Oregano Oil Joy of the Mountains Oregano Oil: Oregano Oil has antimicrobial and anti-inflammatory qualities, and is of use in COPD to prevent pulmonary infection and reduce pulmonary inflammation.

The Oregano oil may be diluted in juice or mixed with olive oil to dilute further.  Start with one drop and gradually work up as tolerates.  Some people report good results with inhaled organo oil in a steamer or nebulizer.  However use with caution as the oil may be very strong undiluted.

Useful Books on Natural Treatments for COPD

Credit and Thanks goes to Dr. Jonathan Wright and Dr Julian Whitaker for much of the information in this article.

Jeffrey Dach MD

7450 Griffin Road Suite 190

Davie, Fl 33314

954-792-4663

Links and References

Salmeterol

Patients with COPD often require multiple therapies to improve lung function and decrease symptoms and exacerbations. Salmeterol and theophylline are indicated for the treatment of COPD, but the use of these agents in combination has not been extensively studied.

OBJECTIVES:  To compare the efficacy and safety of salmeterol plus theophylline vs either agent alone in COPD.

METHODS:  Randomized, double-blind, double-dummy, parallel-group trial in 943 patients with COPD. After an open-label theophylline titration period (serum levels, 10 to 20 microg/mL), patients were randomly assigned to receive salmeterol (42 microg bid) plus theophylline, salmeterol (42 microg bid), or theophylline for 12 weeks. Serial pulmonary function tests were completed on day 1 and treatment week 12. Patients kept diary cards and noted their peak flow rates, symptom scores, and albuterol use, and periodically completed quality-of-life and dyspnea questionnaires.

RESULTS:  All three groups significantly improved compared with baseline. Combination treatment with salmeterol plus theophylline provided significantly (p < or = 0.045) greater improvements in pulmonary function; significantly (p < or = 0.048) greater decreases in symptoms, dyspnea, and albuterol use; and significantly fewer COPD exacerbations (p = 0.023 vs theophylline). In general, treatment with salmeterol provided greater improvement in lung function and satisfaction with treatment compared with theophylline. Salmeterol treatment was also associated with significantly fewer drug-related adverse events (p < or = 0.042) than either treatment that included theophylline. The safety profile (adverse events, vital signs, and ECG findings) of the two treatments that included theophylline were similar.

CONCLUSION:  Patients with COPD may benefit from combination treatment with salmeterol plus theophylline, without a resulting increase in adverse events or other adverse sequelae.

Links and References

Link to this page:  http://wp.me/p3gFbV-2Iu

Source:  Jeffrey Dach

Exit mobile version